Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial+Estimate
Composite+Estimate
500+Stocks+Estimate
Gold
Crude+Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,003.85
-1.12 (-0.11%)
Streaming Delayed Price
Updated: 12:55 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,075,693
Open
1,006.98
Bid (Size)
1,003.38 (160)
Ask (Size)
1,004.32 (80)
Prev. Close
1,004.97
Today's Range
998.75 - 1,014.38
52wk Range
623.78 - 1,133.95
Shares Outstanding
956,580,893
Dividend Yield
0.69%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Buy, Sell, or Hold Novo Nordisk at $46?
↗
Today 11:05 EDT
Can Novo Nordisk thrive under intense competitive pressures?
Via
The Motley Fool
My Top 3 Healthcare Stocks for May 2026
↗
Today 8:53 EDT
Healthcare is booming, and these three companies stand to profit handsomely from growing demand for medications and surgeries.
Via
The Motley Fool
Performance
YTD
-7.1%
-7.1%
1 Month
+8.8%
+8.8%
3 Month
-3.3%
-3.3%
6 Month
-1.9%
-1.9%
1 Year
+40.3%
+40.3%
More News
Read More
This Hot Weight-Loss Drug Stock May Have a Surprise Challenger
May 14, 2026
Via
Barchart.com
Topics
Earnings
Lawsuit
Eli Lilly & Co. (NYSE:LLY) Passes the "Little Book That Makes You Rich" Growth Screen
↗
May 11, 2026
Via
Chartmill
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?
↗
May 14, 2026
Via
The Motley Fool
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook
↗
May 14, 2026
Via
MarketBeat
This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst
↗
May 13, 2026
Via
Benzinga
Is Novo Nordisk's Rebound for Real--or Just a Head Fake?
↗
May 13, 2026
Via
The Motley Fool
Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss
↗
May 13, 2026
Via
Benzinga
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Avoid
May 13, 2026
Via
StockStory
Topics
Retirement
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment
May 12, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Eli Lilly (LLY) Stock Trades Up, Here Is Why
May 12, 2026
Via
StockStory
Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In Obesity
↗
May 12, 2026
Via
Investor's Business Daily
Topics
Initial Public Offering
Why Hims & Hers Health Stock Just Crashed
↗
May 12, 2026
Via
The Motley Fool
Topics
Earnings
Lawsuit
The 3 Best S&P 500 Stocks to Buy Now
↗
May 12, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Credit Cards
Economy
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
Via
FinancialNewsMedia
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
From
MarketNewsUpdates.com
Via
GlobeNewswire
Income or Growth: Which Healthcare Stock Fits Your Portfolio Right Now?
↗
May 11, 2026
Via
The Motley Fool
Topics
Economy
Retirement
Stocks
BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly
May 11, 2026
Via
Investor Brand Network
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026
Via
Investor Brand Network
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026
From
BioMedWire
Via
GlobeNewswire
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
↗
May 09, 2026
Via
The Motley Fool
GoodRx (GDRX) Q1 2026 Earnings Call Transcript
↗
May 08, 2026
Via
The Motley Fool
Topics
Earnings
Omada Health (OMDA) Q1 2026 Earnings Transcript
↗
May 08, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.
↗
May 08, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,003.85
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 05/15/26 12:55 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 960.26B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 960B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.